Clinical Trial Update: Intravitreal Aflibercept for Treatment of Polypoidal Choroidal Vasculopathy (PCV) [Phase 4]

View source ↗

Summary

Phase 4 trial updating intravitreal aflibercept for treatment of symptomatic macular polypoidal choroidal vasculopathy (PCV) completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Polypoidal Choroidal Vasculopathy
• Symptomatic Macular Polypoidal Choroidal Vasculopathy

Drugs mentioned

• intravitreal aflibercept (aflibercept)

Snippet

Sponsor: Department of Medical Services Ministry of Public Health of Thailand | Conditions: Symtomatic Macular Polypoidal Choroidal Vasculopathy | Phase 4 | Status: COMPLETED